Three BC Cancer clinical investigators are participating in the Canadian Cancer Trials Group (CCTG) VISION – Investigator Leadership Training Program, a new education and mentorship initiative focused on developing leadership skills among current and emerging clinical trialists.
Drs. Leah Lambert, Jonathan Loree and Lucia Nappi are part of the inaugural VISION cohort.
BC Cancer’s Molecular Imaging and Therapeutics Program has been recognized with the Canadian Nuclear Isotope Council (CNIC) Award for Academic Leadership — a national honour celebrating the team’s visionary leadership and impact.
At the April CNIC Annual Awards Reception at the National Arts Centre in Ottawa, Dr. François Bénard, senior executive director, Research, BC Cancer accepted the award on behalf the team, including Dr. Joseph Lau, Dr. Carlos Uribe, Dr. Arman Rahmim, Dr. Kuo-Shyan Lin, Dr. Don Wilson and many others.
Researchers at BC Cancer Research Institute (BCCRI) and UBC Chemistry have created a new way to build radioactive DNA molecules that could help reimagine how radiolabeled drugs are built. Using enzymes that normally copy genetic material, scientists programmed synthetic DNA to carry cancer‑fighting isotopes in precise patterns, opening the door to developing drugs that could both image tumors and destroy them with the same molecule.
A new study published in Genetics in Medicine examines how systemic barriers in health care shape Indigenous families’ views about genomic medicine in British Columbia. The research finds that physical and relational barriers to access, experiences of racism and persistent demands for self-advocacy impose resilience as a condition of care for Indigenous families.
A new multinational study led by Dr. Poul Sorensen, distinguished scientist at BC Cancer Research Institute, professor in the UBC Faculty of Medicine and holder of the Johal Chair in Childhood Cancer Research, has been published in Cancer Discovery, a leading journal of the American Association for Cancer Research.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.